ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Is there still an open window in metastatic castration resistant prostate cancer immunotherapy horizon?
Translational Cancer Research
◽
10.21037/tcr.2016.11.05
◽
2016
◽
Vol 5
(S6)
◽
pp. S1061-S1065
Author(s):
Chiara Ciccarese
◽
Giampaolo Tortora
◽
Rodolfo Montironi
◽
Francesco Massari
Keyword(s):
Prostate Cancer
◽
Cancer Immunotherapy
◽
Castration Resistant Prostate Cancer
◽
Castration Resistant
◽
Open Window
Download Full-text
Related Documents
Cited By
References
Emerging treatments for metastatic castration-resistant prostate cancer: Immunotherapy, PARP inhibitors, and PSMA-targeted approaches
Cancer Treatment and Research Communications
◽
10.1016/j.ctarc.2020.100164
◽
2020
◽
Vol 23
◽
pp. 100164
◽
Cited By ~ 1
Author(s):
Catherine Handy Marshall
◽
Emmanuel S. Antonarakis
Keyword(s):
Prostate Cancer
◽
Cancer Immunotherapy
◽
Parp Inhibitors
◽
Castration Resistant Prostate Cancer
◽
Castration Resistant
◽
Emerging Treatments
Download Full-text
Results of the randomized, placebo-controlled phase I/IIB trial of CV9104, an mRNA based cancer immunotherapy, in patients with metastatic castration-resistant prostate cancer (mCRPC)
Annals of Oncology
◽
10.1093/annonc/mdx376.014
◽
2017
◽
Vol 28
◽
pp. v408-v409
◽
Cited By ~ 3
Author(s):
A. Stenzl
◽
S. Feyerabend
◽
I. Syndikus
◽
T. Sarosiek
◽
H. Kübler
◽
...
Keyword(s):
Prostate Cancer
◽
Phase I
◽
Cancer Immunotherapy
◽
Castration Resistant Prostate Cancer
◽
Castration Resistant
Download Full-text
Neuroendocrine secretory profiles are not associated with treatment response to Lu-177-PSMA-617 radioligand therapy in patients with advanced metastatic castration-resistant prostate cancer
10.1055/s-0040-1708342
◽
2020
◽
Author(s):
T Derlin
◽
R Werner
◽
C Henkenberens
◽
TL Ross
◽
FM Bengel
Keyword(s):
Prostate Cancer
◽
Treatment Response
◽
Castration Resistant Prostate Cancer
◽
Radioligand Therapy
◽
Castration Resistant
Download Full-text
Prostate specific membrane antigen targeted radioligand therapy of metastatic castration-resistant prostate cancer using Lu-177 PSMA-617: safety, efficacy and dosimetry in comparison with Lu-177 PSMA I&T
Endocrine Abstracts
◽
10.1530/endoabs.47.oc32
◽
2016
◽
Author(s):
Harshad R. Kulkarni
◽
Aviral Singh
◽
Christiane Schuchardt
◽
Karin Niepsch
◽
Richard P. Baum
Keyword(s):
Prostate Cancer
◽
Prostate Specific Membrane Antigen
◽
Castration Resistant Prostate Cancer
◽
Radioligand Therapy
◽
Castration Resistant
◽
Specific Membrane
Download Full-text
New combination therapies for castration-resistant prostate cancer
Oncology Abstracts
◽
10.1530/oncolabs.1.p031
◽
2019
◽
Author(s):
Mitchell G Lawrence
◽
Laura H Porter
◽
Daisuke Obinata
◽
Shahneen Sandhu
◽
Luke A Selth
◽
...
Keyword(s):
Prostate Cancer
◽
New Combination
◽
Combination Therapies
◽
Castration Resistant Prostate Cancer
◽
Castration Resistant
Download Full-text
The role of microbiota in driving castration-resistant prostate cancer
10.26226/morressier.5f69edb69b74b699bf38c5cf
◽
2020
◽
Author(s):
Arianna Calcinotto
Keyword(s):
Prostate Cancer
◽
Castration Resistant Prostate Cancer
◽
Castration Resistant
Download Full-text
FDA approves darolutamide for non-metastatic castration-resistant prostate cancer
Case Medical Research
◽
10.31525/cmr-1904aca
◽
2019
◽
Author(s):
Keyword(s):
Prostate Cancer
◽
Castration Resistant Prostate Cancer
◽
Castration Resistant
Download Full-text
A Trial Evaluating the Efficacy and Safety of HC-1119 Soft Capsules in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC).
Case Medical Research
◽
10.31525/ct1-nct03851640
◽
2019
◽
Author(s):
Keyword(s):
Prostate Cancer
◽
Efficacy And Safety
◽
Castration Resistant Prostate Cancer
◽
Castration Resistant
Download Full-text
177Lu-PSMA-617 Therapy and Olaparib in Patients With Metastatic Castration Resistant Prostate Cancer
Case Medical Research
◽
10.31525/ct1-nct03874884
◽
2019
◽
Author(s):
Keyword(s):
Prostate Cancer
◽
Castration Resistant Prostate Cancer
◽
Castration Resistant
Download Full-text
Study of REGN5678 (Anti-PSMAxCD28) With Cemiplimab (Anti-PD-1) in Patients With Metastatic Castration-resistant Prostate Cancer
Case Medical Research
◽
10.31525/ct1-nct03972657
◽
2019
◽
Author(s):
Keyword(s):
Prostate Cancer
◽
Castration Resistant Prostate Cancer
◽
Castration Resistant
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close